Cargando…

Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study

Objective: We explored the clinical regularity and prognosis of lung carcinoma (LC) patients with hypercoagulability, which is often associated with the occurrence and development of tumors. Methods: This retrospective study analyzed 624 LC patients diagnosed from 2010-2017 in the Beijing Hospital o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yunfei, Li, Guangda, Li, Xiaoxiao, Gao, Yu, Ding, Tongjing, Yang, Guowang, Zhang, Yi, Nian, Jiayun, Yu, Mingwei, Wang, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040890/
https://www.ncbi.nlm.nih.gov/pubmed/33854597
http://dx.doi.org/10.7150/jca.46600
_version_ 1783677856385073152
author Ma, Yunfei
Li, Guangda
Li, Xiaoxiao
Gao, Yu
Ding, Tongjing
Yang, Guowang
Zhang, Yi
Nian, Jiayun
Yu, Mingwei
Wang, Xiaomin
author_facet Ma, Yunfei
Li, Guangda
Li, Xiaoxiao
Gao, Yu
Ding, Tongjing
Yang, Guowang
Zhang, Yi
Nian, Jiayun
Yu, Mingwei
Wang, Xiaomin
author_sort Ma, Yunfei
collection PubMed
description Objective: We explored the clinical regularity and prognosis of lung carcinoma (LC) patients with hypercoagulability, which is often associated with the occurrence and development of tumors. Methods: This retrospective study analyzed 624 LC patients diagnosed from 2010-2017 in the Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, China. Kaplan-Meier analysis was used to estimate survival and the log-rank test was used to identify differences in survival between groups. The predictive power of a hypercoagulation model was tested using receiver operating characteristic (ROC) curve analysis. Univariate and multivariate Cox regression analyses were performed to explore independent factors associated with survival. A logistic regression model was used to explore factors related to hypercoagulability. The diagnostic power of relevant influencing factors on hypercoagulability was tested using ROC curve analysis. Results: Of 624 patients in the study, 161(25.8%) had hypercoagulability and 463 did not (normal group). The overall survival (OS) of the hypercoagulability group was significantly lower than the normal group (P < 0.0001). The ROC curve showed that the predictive power of the hypercoagulability model was better than that of a single coagulation indicator (P < 0.01). Both univariate and multivariate Cox regression analyses showed that hypercoagulability was an independent factor affecting the prognosis of LC (P<0.0001). The results of the logistic regression analysis showed that clinical stage (P < 0.05), cytokeratin 19 fragment (Cyfra211) (P < 0.05), and the platelet-to-lymphocyte ratio (PLR) (P < 0.05) were positively correlated with hypercoagulability. When combining clinical stage, Cyfra211, and the PLR to predict hypercoagulability, the area under the ROC curve was 0.797 (P < 0.01). Conclusions: In LC, hypercoagulability is an independent factor associated with poor OS and could be a prognostic factor.
format Online
Article
Text
id pubmed-8040890
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-80408902021-04-13 Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study Ma, Yunfei Li, Guangda Li, Xiaoxiao Gao, Yu Ding, Tongjing Yang, Guowang Zhang, Yi Nian, Jiayun Yu, Mingwei Wang, Xiaomin J Cancer Research Paper Objective: We explored the clinical regularity and prognosis of lung carcinoma (LC) patients with hypercoagulability, which is often associated with the occurrence and development of tumors. Methods: This retrospective study analyzed 624 LC patients diagnosed from 2010-2017 in the Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, China. Kaplan-Meier analysis was used to estimate survival and the log-rank test was used to identify differences in survival between groups. The predictive power of a hypercoagulation model was tested using receiver operating characteristic (ROC) curve analysis. Univariate and multivariate Cox regression analyses were performed to explore independent factors associated with survival. A logistic regression model was used to explore factors related to hypercoagulability. The diagnostic power of relevant influencing factors on hypercoagulability was tested using ROC curve analysis. Results: Of 624 patients in the study, 161(25.8%) had hypercoagulability and 463 did not (normal group). The overall survival (OS) of the hypercoagulability group was significantly lower than the normal group (P < 0.0001). The ROC curve showed that the predictive power of the hypercoagulability model was better than that of a single coagulation indicator (P < 0.01). Both univariate and multivariate Cox regression analyses showed that hypercoagulability was an independent factor affecting the prognosis of LC (P<0.0001). The results of the logistic regression analysis showed that clinical stage (P < 0.05), cytokeratin 19 fragment (Cyfra211) (P < 0.05), and the platelet-to-lymphocyte ratio (PLR) (P < 0.05) were positively correlated with hypercoagulability. When combining clinical stage, Cyfra211, and the PLR to predict hypercoagulability, the area under the ROC curve was 0.797 (P < 0.01). Conclusions: In LC, hypercoagulability is an independent factor associated with poor OS and could be a prognostic factor. Ivyspring International Publisher 2021-03-19 /pmc/articles/PMC8040890/ /pubmed/33854597 http://dx.doi.org/10.7150/jca.46600 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Ma, Yunfei
Li, Guangda
Li, Xiaoxiao
Gao, Yu
Ding, Tongjing
Yang, Guowang
Zhang, Yi
Nian, Jiayun
Yu, Mingwei
Wang, Xiaomin
Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study
title Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study
title_full Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study
title_fullStr Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study
title_full_unstemmed Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study
title_short Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study
title_sort clinical characteristics and prognostic analysis of lung cancer patients with hypercoagulability: a single-center, retrospective, real-world study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040890/
https://www.ncbi.nlm.nih.gov/pubmed/33854597
http://dx.doi.org/10.7150/jca.46600
work_keys_str_mv AT mayunfei clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT liguangda clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT lixiaoxiao clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT gaoyu clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT dingtongjing clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT yangguowang clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT zhangyi clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT nianjiayun clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT yumingwei clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy
AT wangxiaomin clinicalcharacteristicsandprognosticanalysisoflungcancerpatientswithhypercoagulabilityasinglecenterretrospectiverealworldstudy